Grimbergen JM - Search Results

1

TR3 orphan receptor is expressed in vascular endothelial cells and mediates cell cycle arrest.

Arkenbout EK, van Bragt M, Eldering E, van Bree C, Grimbergen JM, Quax PH, Pannekoek H, de Vries CJ. Arkenbout EK, et al. Among authors: grimbergen jm. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1535-40. doi: 10.1161/01.ATV.0000084639.16462.7A. Epub 2003 Jul 3. Arterioscler Thromb Vasc Biol. 2003. PMID: 12842839

2

Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice.

Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, de Vries CJ. Arkenbout EK, et al. Among authors: grimbergen jm. Circulation. 2002 Sep 17;106(12):1530-5. doi: 10.1161/01.cir.0000028811.03056.bf. Circulation. 2002. PMID: 12234960

3

Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.

Engelse MA, Lardenoye JH, Neele JM, Grimbergen JM, De Vries MR, Lamfers ML, Pannekoek H, Quax PH, De Vries CJ. Engelse MA, et al. Among authors: grimbergen jm. Circ Res. 2002 May 31;90(10):1128-34. doi: 10.1161/01.res.0000021044.53156.f5. Circ Res. 2002. PMID: 12039804

4

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH. Schepers A, et al. Among authors: grimbergen jm. Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2063-9. doi: 10.1161/01.ATV.0000235694.69719.e2. Epub 2006 Jul 6. Arterioscler Thromb Vasc Biol. 2006. PMID: 16825596

5

Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.

Lamfers ML, Aalders MC, Grimbergen JM, de Vries MR, Kockx MM, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: grimbergen jm. Vascul Pharmacol. 2002 Dec;39(6):293-301. doi: 10.1016/s1537-1891(03)00043-0. Vascul Pharmacol. 2002. PMID: 14567067

6

Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.

Quax PH, Grimbergen JM, Lansink M, Bakker AH, Blatter MC, Belin D, van Hinsbergh VW, Verheijen JH. Quax PH, et al. Among authors: grimbergen jm. Arterioscler Thromb Vasc Biol. 1998 May;18(5):693-701. doi: 10.1161/01.atv.18.5.693. Arterioscler Thromb Vasc Biol. 1998. PMID: 9598826

7

Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.

Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH. Lardenoye JH, et al. Among authors: grimbergen jm. Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1433-8. doi: 10.1161/01.atv.0000030339.79524.6e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12231562

8

In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.

Eefting D, de Vries MR, Grimbergen JM, Karper JC, van Bockel JH, Quax PH. Eefting D, et al. Among authors: grimbergen jm. J Vasc Surg. 2010 Feb;51(2):429-37. doi: 10.1016/j.jvs.2009.09.026. Epub 2009 Dec 24. J Vasc Surg. 2010. PMID: 20036101 Free article.

9

Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.

Lamfers ML, Wijnberg MJ, Grimbergen JM, Huisman LG, Aalders MC, Cohen FN, Verheijen JH, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: grimbergen jm. Thromb Haemost. 2000 Sep;84(3):460-7. Thromb Haemost. 2000. PMID: 11019972

10

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.

Lamfers ML, Grimbergen JM, Aalders MC, Havenga MJ, de Vries MR, Huisman LG, van Hinsbergh VW, Quax PH. Lamfers ML, et al. Among authors: grimbergen jm. Circ Res. 2002 Nov 15;91(10):945-52. doi: 10.1161/01.res.0000041418.51906.57. Circ Res. 2002. PMID: 12433840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters